Enterohemorrhagic E. coli bacteriophage Esc-CHP-1 and use thereof for inhibiting proliferation of enterohemorrhagic E. coli
AssigneeIntron Biotechnology, Inc.
InventorsSeong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Byung Kuk Kim, Hee Jeong Shin
Life of this patent
Estimating the term…
Abstract
The present invention relates to a Myoviridae bacteriophage Esc-CHP-1 that is isolated from the nature and can kill specifically enterohemorrhagic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12660BP), and a method for preventing and treating the infections of enterohemorrhagic E. coli using the composition comprising said bacteriophage as an active ingredient.
Claims2
A method for preventing or treating infections of enterohemorrhagic E. coli in a subject, the method comprising a step of administering to the subject a composition comprising Myoviridae bacteriophage Esc-CHP-1 (Accession NO:
- KCTC 12660BP) that is isolated from nature and can kill enterohemorrhagic E. coli specifically, which has the genome represented by the nucleotide sequence of SEQ ID NO:
- 1, as an active ingredient.
Dependencies are inferred from the claim text.